Rigel Pharmaceuticals Inc (RIGL) insider trading.
In Q3 2026, insiders at Rigel Pharmaceuticals Inc reported 9 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-03
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schorno Dean L | Officer · EVP & Chief Financial Officer | 5 | 0 | 0 |
| Furey Raymond J. | Officer · EVP, GC, CCO & Corp Sec | 1 | 0 | 0 |
| Rodriguez Raul R | Director, Officer · CEO, President | 1 | 0 | 0 |
| Santos David A | Officer · EVP, Chief Commercial Officer | 1 | 0 | 0 |
| Hannah Alison L. | Officer · EVP, Chief Medical Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L | M (A) | 694 | $12.7 | 79,056 | Form 4 |
| 2026-09-02 | Schorno Dean L | M (A) | 1,286 | $24.2 | 82,962 | Form 4 |
| 2026-09-02 | Schorno Dean L | M (A) | 2,000 | $24.2 | 81,676 | Form 4 |
| 2026-09-02 | Schorno Dean L | M (A) | 620 | $18.7 | 79,676 | Form 4 |
| 2026-09-01 | Furey Raymond J. | F (D) | 877 | $47.5 | 50,559 | Form 4 |
| 2026-09-01 | Rodriguez Raul R | F (D) | 2,424 | $47.5 | 273,362 | Form 4 |
| 2026-09-01 | Santos David A | F (D) | 874 | $47.5 | 61,622 | Form 4 |
| 2026-09-01 | Schorno Dean L | F (D) | 928 | $47.5 | 78,362 | Form 4 |
| 2026-07-08 | Hannah Alison L. | A (A) | 24,400 | $0 | 35,025 | Form 4 |
Transaction codes in this quarter
Get RIGL insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1034842&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · RIGL company page · Rigel Pharmaceuticals Inc on SEC.gov
Questions
Are insiders buying or selling Rigel Pharmaceuticals Inc (RIGL)?
In Q3 2026, insiders at Rigel Pharmaceuticals Inc reported 9 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Rigel Pharmaceuticals Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/rigl.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.